Why Test? The Business Case for Incorporating Hereditary Cancer Testing in Your OBGYN Practice

FEATURING

Dr. Richard Frieder, MD, FACOG

Dr. Richard Frieder has over 40+ years of clinical and academic practice experience in OBGYN, most recently as Assistant Professor of Clinical Cancer Genetics, John Wayne Cancer Institute and Assistant Clinical Professor of Obstetrics and Gynecology, UCLA. He has delivered thousands of presentations to 20,000+ clinicians on the value of personalized cancer risk assessment and cancer prevention.

ABOUT THE WEBINAR

OBGYN practices often lack the resources to incorporate patient risk assessment, education, and genetic testing navigation, especially without a genetic counselor on staff. But women’s health is the ideal place to help patients manage their hereditary cancer risk.

This webinar will cover the key clinical and financial reasons for women's health providers to implement genetic testing in their practice and prevent the catastrophe of cancer in their patients' lives. Dr. Frieder will address the business opportunities physicians have to save time and reduce clinical liability by setting up a formal program for hereditary cancer testing in their OBGYN practices.

Participants will walk away with the tools they need to help patients understand their hereditary cancer risk, make shared decisions around genetic testing, and take the right actions based on their individual risk.